Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4404 |  MCRB Seres Therapeutics, Inc. - Common Stock | 2.63 USD | -3.31% | -11.74% | -49.52% | -68.04% | 26.15 M USD | ||
| 4406 |  ABVC ABVC BioPharma, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +6.52% | -69.94% | 26.12 M USD | ||
| 4408 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.26 USD | -7.14% | -10.34% | -44.68% | -73.20% | 25.50 M USD | ||
| 4410 |  EVAX Evaxion A/S - American Depositary Share | 3.05 USD | -2.87% | -5.57% | -7.29% | -8.13% | 25.44 M USD | ||
| 4415 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 0.61 USD | -4.69% | -26.51% | 0.00% | -66.67% | 25.08 M USD | ||
| 4432 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.42 USD | -1.63% | +8.52% | +2.54% | +106.84% | 24.15 M USD | ||
| 4433 |  KYNB Kyntra Bio, Inc. - Common Stock | 5.96 USD | -1.32% | -9.70% | -29.22% | -37.33% | 24.13 M USD | ||
| 4474 |  COCP Cocrystal Pharma, Inc. - Common Stock | 1.07 USD | 0.00% | -8.55% | -15.08% | -13.71% | 20.61 M USD | ||
| 4503 |  JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.56 USD | -1.75% | -6.67% | -18.84% | -77.60% | 18.63 M USD | ||
| 4504 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.42 USD | 0.00% | -8.70% | -32.26% | -66.40% | 18.27 M USD | ||
| 4509 |  NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.35 USD | -2.05% | -6.69% | -11.61% | -82.41% | 18.13 M USD | ||
| 4528 |  GNTA Genenta Science S.p.A. - American Depositary Shares | 0.71 USD | -6.58% | -13.41% | -23.66% | -78.81% | 16.64 M USD | ||
| 4532 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 8.49 USD | -1.62% | -5.77% | -20.13% | +793.68% | 16.53 M USD | ||
| 4538 |  ACTU Actuate Therapeutics, Inc. - Common stock | 0.68 USD | -5.56% | -26.88% | -45.60% | -83.33% | 16.33 M USD | ||
| 4541 |  BCDA BioCardia, Inc. - Common Stock | 1.06 USD | -2.75% | +1.92% | -2.75% | -8.62% | 16.05 M USD | ||
| 4543 |  PTN Palatin Technologies, Inc. Common Stock | 9.01 USD | -5.36% | +3.56% | -26.57% | +24.28% | 16.05 M USD | ||
| 4544 |  DYAI Dyadic International, Inc. - Common Stock | 0.44 USD | -4.35% | -4.35% | -13.73% | -61.06% | 16.03 M USD | ||
| 4546 |  LPCN Lipocine Inc. - Common Stock | 1.93 USD | -12.27% | -8.53% | -17.87% | -33.45% | 15.91 M USD | ||
| 4548 |  MRKR Marker Therapeutics, Inc. - Common Stock | 0.95 USD | -8.65% | -10.38% | -21.49% | -10.38% | 15.84 M USD | ||
| 4554 |  ALLR Allarity Therapeutics, Inc. - Common stock | 0.98 USD | 0.00% | -7.55% | -24.03% | -44.32% | 15.59 M USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |